Comparison of Two Different Doses of Bemiparin in COVID-19

  • participants needed
  • sponsor
    Clinica Universidad de Navarra, Universidad de Navarra
Updated on 16 September 2021
Ramon Lecumberri, MD, PhD
Primary Contact
Hospital Rey Juan Carlos (6.2 mi away) Contact
+9 other location


Patients requiring hospitalization due to COVID-19 pneumonia (non-severe) will be randomized to standard prophylactic doses or full therapeutic dose of bemiparin (a LMWH) for 10 days.

Condition *COVID-19, Covid-19
Treatment Bemiparin sodium
Clinical Study IdentifierNCT04604327
SponsorClinica Universidad de Navarra, Universidad de Navarra
Last Modified on16 September 2021

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note